SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-037493
Filing Date
2017-07-20
Accepted
2017-07-20 16:05:41
Documents
3
Group Members
ALAIN SCHREIBERJAY MOORINPROQUEST ASSOCIATES IV LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G v471160_sc13g.htm SC 13G 109273
2 POWER OF ATTORNEY v471160_ex24-1.htm EX-24.1 5967
3 JOINT FILING AGREEMENT v471160_ex99-1.htm EX-99.1 4823
  Complete submission text file 0001144204-17-037493.txt   121644
Mailing Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109
Business Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109 609-919-3567
ProQuest Investments IV, L.P. (Filed by) CIK: 0001431818 (see all company filings)

IRS No.: 205935001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89992 | Film No.: 17974411
SIC: 2834 Pharmaceutical Preparations